These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16030368)

  • 21. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
    Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid management and cholesterol goal attainment in Norway.
    Ose L; Skjeldestad FE; Bakken IJ; Levorsen A; Alemao EA; Yin DD; Borgström F; Jönsson L
    Am J Cardiovasc Drugs; 2006; 6(2):121-8. PubMed ID: 16555865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.
    Sangsawang T; Sriwijitkamol A
    Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiology management improves secondary prevention measures among patients with coronary artery disease.
    Ho PM; Masoudi FA; Peterson ED; Grunwald GK; Sales AE; Hammermeister KE; Rumsfeld JS
    J Am Coll Cardiol; 2004 May; 43(9):1517-23. PubMed ID: 15120805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M; Okopień B; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
    Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
    Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time trends of gender-based differences in lipid goal attainments during secondary prevention of coronary artery disease: results of a 5-year survey.
    Singh M; Chin SH; Crothers D; Giles P; Al-Allaf K; Khan JM
    Am J Ther; 2013; 20(6):613-7. PubMed ID: 23344096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practice patterns in treating high-risk patients with hyperlipidemia at a northeast Tennessee university clinic.
    Ismail HM; Simmons C; Pfortmiller D
    J Investig Med; 2005 Jan; 53(1):31-6. PubMed ID: 16025879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reaching C-reactive protein and low-density lipoprotein cholesterol goals in dyslipidemic patients (from the Lipid Treatment Assessment Project [L-TAP] 2).
    Chiang CW; Santos RD; Waters DD; Messig M; Tarasenko L; Jukema JW; Ferrières J; Foody J; Seung KB;
    Am J Cardiol; 2011 Jun; 107(11):1639-43. PubMed ID: 21440886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and treatment of lipid disorders in women.
    Zelis R
    Curr Womens Health Rep; 2003 Apr; 3(2):97-103. PubMed ID: 12628078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic determinants of response to statin medications.
    Cone C; Murata G; Myers O
    Am J Health Syst Pharm; 2011 Mar; 68(6):511-7. PubMed ID: 21378299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP)].
    Roden M; Huber K;
    Wien Klin Wochenschr; 2008; 120(17-18):558-65. PubMed ID: 18988009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
    Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
    Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.